EUVIMEDEUVIMED entdecken
Crossref

Liposome‐Based Permeable Eyedrops for Effective Posterior Segment Drug Delivery

Ying Wang, Yanhong Hu, Jinying An, Hui Zhang, Xun Liu, Xiaorong Li, Zhanzhan Zhang, Xiaomin Zhang

Advanced Functional Materials · 2024-09 · 34 (39)

DOI: 10.1002/adfm.202403142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 12.06.2024. Verfasst von Ying Wang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Municipal Science and Technology Bureau.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topical eyedrop administration is identified as an ideal non‐invasive strategy for ocular drug delivery. However, multiple complex ocular barriers greatly restrict their effectiveness in the treatment of posterior ocular disease. Herein, a liposome‐based permeable eyedrops (pDrops) capable of overcoming multiple ocular barriers and achieving efficient posterior drug delivery is presented. pDrops have a core‐shell structure in which drugs are encapsulated inside the liposome core with a chitosan shell. This chitosan coating significantly enhances the pDrops’ binding to mucin in tears and facilitates the temporary opening of tight junctions in cornea/conjunctive epithelial cells, thereby achieving prolonged preocular retention and enhanced posterior segment drug delivery. In this study, hydrophilic ganciclovir (GCV) and hydrophobic curcumin (CUR) are employed as model drugs. Upon topical instillation, pDrops effectively overcome ocular barriers and delivered GCV to the posterior segment in both rat and rabbit eyes. Notably, CUR delivery by pDrops demonstrates significantly enhanced therapeutic efficacy in light‐damaged retina of mice. Considering that pDrops can deliver both hydrophobic and hydrophilic drugs to the posterior segment of the eye, it can potentially become a feasible platform for the non‐invasive delivery of various drug molecules and improve the treatment efficiency of posterior ocular diseases.

Förderung

  • National Natural Science Foundation of China
  • Tianjin Municipal Science and Technology Bureau

Zitieren

APA

Wang, Y., Hu, Y., An, J., Zhang, H., Liu, X., Li, X., Zhang, Z., & Zhang, X. (2024). Liposome‐Based Permeable Eyedrops for Effective Posterior Segment Drug Delivery. Advanced Functional Materials, 34(39). https://doi.org/10.1002/adfm.202403142

Vancouver

Wang Y, Hu Y, An J, Zhang H, Liu X, Li X, et al. Liposome‐Based Permeable Eyedrops for Effective Posterior Segment Drug Delivery. Advanced Functional Materials. 2024;34(39). doi:10.1002/adfm.202403142

BibTeX
@article{Wang2024,
  author = {Wang, Ying and Hu, Yanhong and An, Jinying and Zhang, Hui and Liu, Xun and Li, Xiaorong and Zhang, Zhanzhan and Zhang, Xiaomin},
  title = {Liposome‐Based Permeable Eyedrops for Effective Posterior Segment Drug Delivery},
  journal = {Advanced Functional Materials},
  year = {2024},
  volume = {34},
  number = {39},
  doi = {10.1002/adfm.202403142}
}
Kostenlos starten →